Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency.Ann Hematol. 2016; 95: 451-455
- Congenital factor XIII deficiency in women: a systematic review of literature.Haemophilia. 2013; 19: e349-e357
- Factor XIII deficiency.Haemophilia. 2008; 14: 1190-1200
- Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine.Science. 1968; 160: 892-893
- Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.Int J Hematol. 2014; 100: 443-449
- Rare bleeding disorders: diagnosis and treatment.Blood. 2015; 125: 2052-2061
- Factor XIII deficiency.Br J Haematol. 1999; 107: 468-484
- Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort.Br J Haematol. 2020; 188: 317-320
- Factor XIII a subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages.Blood. 2003; 102: 4410-4412
- Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature.Obstet Gynecol Surv. 2007; 62: 255-260
- Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.J Thromb Haemost. 2012; 10: 615-621
- Minimal factor XIII activity level to prevent major spontaneous bleeds.J Thromb Haemost. 2017; 15: 1728-1736
- Acquired factor XIII deficiency: a review.Transfus Apher Sci. 2018; 57: 724-730
- Acquired Factor XIII inhibitor associated with mantle cell lymphoma.Transfusion. 2017; 57: 694-699
- Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: a summary of 93 patients.Blood Rev. 2017; 31: 37-45
- Factor XIII and fibrinogen SSC subcommittee of the ISTH. Diagnosis and classification of factor XIII deficiencies.J Thromb Haemost. 2011; 9: 1404-1406
- Recessively inherited coagulation disorders.Blood. 2004; 104: 1243-1252
- A pasteurized concentrate of human plasma factor XIII for therapeutic use.Thromb Haemost. 1986; 55: 402-405
- Corifact™/Fibrogammin® P in the prophylactic treatment of hereditary factor XIII deficiency: results of a prospective, multicenter, open-label study.Thromb Res. 2012; 130: S12-S14
- Safety of factor XIII concentrate: analysis of more than 20 years of pharmacovigilance data.Transfus Med Hemother. 2016; 43: 365-373
- Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency.Blood. 2012; 119: 5111-5117
- The rare coagulation disorders--review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.Haemophilia. 2004; 10: 593-628
- Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study.J Thromb Haemost. 2003; 1: 2603-2608
- Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell.Placenta. 2000; 21: 388-393
- Use of factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures.Transfusion. 2014; 55: 45-50
- Recombinant FXIII (rFXIII-A2) prophylaxis prevents bleeding and allows for surgery in patients with congenital FXIII A-subunit deficiency.Thromb Haemost. 2018; 118: 451-460
- Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency.J Thromb Haemost. 2003; 1: 1852-1853
- Rare bleeding disorder registry: de®ciencies of factors II, V, VII,X, XIII, ®brinogen and dys®brinogenemias.J Thromb Haemost. 2004; 2: 248-256
- International registry on factor XIII deficiency: a basis formed mostly on European data.Thromb Haemost. 2007; 97: 914-921
- Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India.Haemophilia. 2012; 18: e195-e200
Article info
Publication history
Published online: October 01, 2021
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
